MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Non-motor Scales"

  • 2017 International Congress

    Segregation of subjective and objective clinical measures in Parkinson’s disease

    K. Markopoulou, R. Frigerio, A. Premkumar, B. Schoneburg, M. Dudek, S. Walters, C. Wang, D. Maraganore (Evanston, IL, USA)

    Objective: Use standardized measures to characterize disease severity, progression, and outcomes in Parkinson’s disease (PD). Background: Subjective and objective standardized measures are usually performed in…
  • 2017 International Congress

    Motor complications and others of therapy but not non-motor symptoms burden predict short-term mortality in non-demented Parkinson´s disease patients

    D. Santos García, E. Suárez Castro, I. Expósito Ruíz, C. Tuñas Gesto, M. Aneiros Díaz, M. López Fernández, T. de Deus, D. Núñez Arias, J. Ernández (Ferrol, Spain)

    Objective: To identify independent risk factors of mortality in a community-based Parkinson´s disease (PD) cohort during prospective long-term follow-up. Specifically, we analized the effect of…
  • 2017 International Congress

    Non-motor features of p.A53T α-synuclein mutation carriers compared to sporadic Parkinson’s disease in a PPMI cohort .

    M. Stamelou, C. Koros, A. Simitsi, I. Beratis, X. Geronicola Trapali, D. Papadimitriou, N. Papagiannakis, A. Prentakis, D. Kontaxopoulou, S. Fragkiadaki, R. Antonelou, S. Papageorgiou, L. Stefanis (Athens, Greece)

    Objective: To evaluate the prevalence of non-motor symptoms in p.A53T SNCA-related PD patients as compared to sporadic PD (sPD) patients. Background: p.A53T α-synuclein (SNCA) mutation…
  • 2017 International Congress

    The hardest symptoms that bother patients with Parkinson’s disease

    V. Vuletic (Rijeka, Croatia)

    Objective: In this study we want to see what are the hardest and the most troublesome symptoms perceived by patients with Parkinson’s disease (PD). Background:…
  • 2017 International Congress

    NonMotor and Motor symptoms in Idiopathic Parkinson´s Disease and Secondary parkinsonism The “Parkinsons Well-Being MapTM” – a useful instrument in Clinical praxis.

    Ö. Skogar, M. Nilsson, S. Morberg (Jönköping SWEDEN, Sweden)

    Objective: To evaluate self-reported frequency and amplitude of the spectra of motor (MS) and Non Motor Symptoms (NMS) presented in the “Parkinsons Well-Being MapTM ”…
  • 2017 International Congress

    Non-motor symptoms in Parkinsons’s disease patients treated with levodopa-carbidopa intestinal gel infusion- the follow up study

    A. Križnar, N. Zupančič Križnar, M. Kramberger, J. Bon, R. Rajnar, L. Ocepek, Z. Pirtošek, M. Trošt (Ljubljana, Slovenia)

    Objective: To follow up the effect of continuous levodopa-carbidopa intestinal gel infusion (LCIG) on motor and non-motor symptoms in advanced Parkinson’s disease (aPD). Background: Non-motor…
  • 2017 International Congress

    Substantial psychiatric symptoms, sleep disturbances and reduced quality of life in well-treated adult patients with GTP-cyclohydrolase deficient dopa-responsive dystonia

    A. Kuiper, E. Timmers, M. Smit, T. De Koning, M. Tijssen (Groningen, Netherlands)

    Objective: The aim of this study was to systematically investigate the prevalence of psychiatric disorders, sleep problems and health-related quality of life (HRQoL) in patients…
  • 2017 International Congress

    Profiling the Non Motor Symptoms burden in Parkinson’s disease patients in Nigeria

    T. Farombi, A. Ogunniyi (Ibadan, Nigeria)

    Objective: To determine the frequency of Non- motor symptoms (NMS) burden using the non-motor symptoms questionnaire (NMSQuest). Background: Over the years, motor manifestations were more associated with…
  • 2017 International Congress

    Self-rated burden grading of nonmotor symptoms identifies landmarks and subtypes of Parkinson’s disease: first report from a Moscow-Madrid-London collaboration

    N. Titova, S. Cankaya, F. Spinnato, E. Katunina, P. Martinez-Martin, M. Qamar, K.R. Chaudhuri (Moscow, Russian Federation)

    Objective: To describe clinical and imaging biomarkers of nonmotor symptoms burden (NMSB) as defined by NMS questionnaire (NMSQ) scores in a prospective international cohort study…
  • 2017 International Congress

    Does the side of onset affect motor and non-motor symptoms in Parkinson’s disease?

    J. Silva, A. D'Abreu (Campinas, Brazil)

    Objective: To assess the association between motor and non-motor symptoms of Parkinson’s Disease (PD) and side of onset considering hand dominance. Background: PD motor symptoms…
  • « Previous Page
  • 1
  • …
  • 41
  • 42
  • 43
  • 44
  • 45
  • …
  • 51
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
    • #25062 (not found)
    • Effect of marijuana on Essential Tremor: A case report
    • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
    • Covid vaccine induced parkinsonism and cognitive dysfunction
    • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
    • Patients with Essential Tremor Live Longer than their Relatives
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley